Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management

Table 4

Summarization of the treatment regimen recommended by the National Hansen’s Disease Program and the United States Health Resources and Services Administration.

Diagnosis	Population	Medication	Dose	Duration
Tuberculoid (TT and BT) (WHO classification paucibacillary)
	Adults
		Rifampicin	600 mg/day	12 months
		Dapsone	100 mg/day	12 months
	Children
		Rifampicin	10–20 mg/kg/day (<600 mg)	12 months
		Dapsone	1 mg/kg/day	12 months
Lepromatous (LL, BL, and BB) (WHO classification multibacillary)
	Adult
		Rifampicin	600 mg/day	24 months
		Clofazimine	50 mg/day	24 months
		Dapsone	100 mg/day	24 months
	Children
		Rifampicin	10–20 mg/kg/day (<600 mg)	24 months
		Clofazimine	1 mg/kg/day	24 months
		Dapsone	1 mg/kg/day	24 months